127 related articles for article (PubMed ID: 20151969)
1. Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.
Beydoun HA; Mohan R; Beydoun MA; Davis J; Lance R; Schellhammer P
BJU Int; 2010 Aug; 106(3):334-41. PubMed ID: 20151969
[TBL] [Abstract][Full Text] [Related]
2. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
3. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
4. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
Kim SP; Knight SJ; Tomori C; Colella KM; Schoor RA; Shih L; Kuzel TM; Nadler RB; Bennett CL
Cancer Invest; 2001; 19(7):684-91. PubMed ID: 11577809
[TBL] [Abstract][Full Text] [Related]
5. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
Formica MK; Wason S; Seigne JD; Stewart TM
Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based patient choice: a prostate cancer decision aid in plain language.
Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
[TBL] [Abstract][Full Text] [Related]
7. Development and psychometric evaluation of the patient's HIV knowledge questionnaire (PHKQ).
Jackson IL; Okonta JM; Ukwe CV
Int J Clin Pharm; 2020 Apr; 42(2):695-702. PubMed ID: 31939032
[TBL] [Abstract][Full Text] [Related]
8. The development and psychometric properties of the bipolar disorders knowledge scale.
Stump TA; Eng ML
J Affect Disord; 2018 Oct; 238():645-650. PubMed ID: 29957482
[TBL] [Abstract][Full Text] [Related]
9. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
10. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
Belkora J; Chan JM; Cooperberg MR; Neuhaus J; Stupar L; Weinberg T; Broering JM; Tenggara I; Cowan JE; Rosenfeld S; Kenfield SA; Van Blarigan EL; Simko JP; Witte J; Carroll PR
Cancer Med; 2020 Jan; 9(1):125-132. PubMed ID: 31714037
[TBL] [Abstract][Full Text] [Related]
11. Predictors of patient preferences and treatment choices for localized prostate cancer.
Sommers BD; Beard CJ; D'Amico AV; Kaplan I; Richie JP; Zeckhauser RJ
Cancer; 2008 Oct; 113(8):2058-67. PubMed ID: 18704993
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of an instrument to measure the informational needs of men with prostate cancer.
Templeton HR; Coates VE
J Adv Nurs; 2001 Aug; 35(3):357-64. PubMed ID: 11489016
[TBL] [Abstract][Full Text] [Related]
13. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Brook RH
Med Care; 1998 Jul; 36(7):1002-12. PubMed ID: 9674618
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
van Stam MA; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Aaronson NK; Ruud Bosch JLH
BJU Int; 2018 Mar; 121(3):405-414. PubMed ID: 28960827
[TBL] [Abstract][Full Text] [Related]
15. Dimensions of quality of life expressed by men treated for metastatic prostate cancer.
Clark JA; Wray N; Brody B; Ashton C; Giesler B; Watkins H
Soc Sci Med; 1997 Oct; 45(8):1299-309. PubMed ID: 9381242
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
[TBL] [Abstract][Full Text] [Related]
17. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
Giesler RB; Miles BJ; Cowen ME; Kattan MW
Qual Life Res; 2000; 9(6):645-65. PubMed ID: 11236855
[TBL] [Abstract][Full Text] [Related]
18. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.
Kane CJ; Lubeck DP; Knight SJ; Spitalny M; Downs TM; Grossfeld GD; Pasta DJ; Mehta SS; Carroll PR
Urology; 2003 Dec; 62(6):1035-9. PubMed ID: 14665350
[TBL] [Abstract][Full Text] [Related]
19. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
[TBL] [Abstract][Full Text] [Related]
20. When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer.
Underhill ML; Hong F; Berry DL
Health Qual Life Outcomes; 2014 Oct; 12():159. PubMed ID: 25344101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
